网站主页 >> CAS数据库列表 >> 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
|
|
|
- CAS号:
- 1228690-19-4
- 英文名:
- (R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid
- 英文别名:
- AM 966;CS-2784;(R)-2-(4'AM 966; AM-966;AM966, 10 mM in DMSO;-biphenyl]-4-yl)acetic acid;AM966,Lysophospholipid Receptor,inhibit,Inhibitor,AM-966,AM 966,LPL Receptor;-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'{4'-[4-({[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]-4-biphenylyl}acetic acid;4'-[4-[[[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]-[1,1'-biphenyl]-4-acetic acid
- 中文名:
- 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
- 中文别名:
- 化合物AM966;化合物AM966,10 MM DMSO 溶液;化合物:AM966 CAS:1228690-19-4;化合物:AM966 CAS:1228690-19-4;4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸;4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸;(R)-2-(4'-(4-(((1-(2-氯苯基)乙氧基)羰基)氨基)-3-甲基异恶唑-5-基)-[1,1'-联苯]-4-基)乙酸;(R)-2-(4'-(4-(((1-(2-氯苯基)乙氧基)羰基)氨基)-3-甲基异恶唑-5-基)-[1,1'-联苯]]-4-基)乙酸
- CBNumber:
- CB52595734
- 分子式:
- C27H23ClN2O5
- 分子量:
- 490.93
- MOL File:
- 1228690-19-4.mol
|
|
|
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸化学性质
-
沸点:
-
659.4±55.0 °C(Predicted)
-
|
-
密度:
-
1.330±0.06 g/cm3 (20 ºC 760 Torr)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
≥24.55 mg/mL in DMSO; insoluble in H2O; ≥2.24 mg/mL in EtOH with gentle warming and ultrasonic
-
|
-
形态:
-
solid
-
|
-
酸度系数(pKa):
-
4.21±0.10(Predicted)
-
|
-
颜色:
-
White to off-white
-
|
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸性质、用途与生产工艺
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸 是一种高亲和性的选择性LPA1-拮抗剂,抑制LPA-刺激的细胞内钙释放,IC50 为 17 nM。
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2026/07/06 | S3534 | 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸 AM966 | 1228690-19-4 | 5mg | 2285.01元 |
| 2026/07/06 | S3534 | 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸 AM966 | 1228690-19-4 | 25mg | 6855.81元 |
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
生产厂家
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸 图谱信息:
1228690-19-4, 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸 相关搜索:
- 抑制剂
- 合成有机化合物配体
- LPA抑制剂分子
- G蛋白偶联受体&G蛋白
- C27H23ClN2O5
- 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
- 化合物:AM966 CAS:1228690-19-4
- 化合物:AM966 CAS:1228690-19-4
- 化合物AM966,10 MM DMSO 溶液
- (R)-2-(4'-(4-(((1-(2-氯苯基)乙氧基)羰基)氨基)-3-甲基异恶唑-5-基)-[1,1'-联苯]-4-基)乙酸
- 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
- 化合物AM966
- (R)-2-(4'-(4-(((1-(2-氯苯基)乙氧基)羰基)氨基)-3-甲基异恶唑-5-基)-[1,1'-联苯]]-4-基)乙酸
- 1228690-19-4
- -biphenyl]-4-yl)acetic acid
- (R)-2-(4'
- -(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'
- AM966, 10 mM in DMSO
- AM966,Lysophospholipid Receptor,inhibit,Inhibitor,AM-966,AM 966,LPL Receptor
- 4'-[4-[[[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]-[1,1'-biphenyl]-4-acetic acid
- AM 966
- (R)-2-(4'-(4-(((1-(2-chlorophenyl)ethoxy)carbonyl)aMino)-3-Methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid
- CS-2784
- AM 966; AM-966
- {4'-[4-({[(1R)-1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]-4-biphenylyl}acetic acid
- [1,1'-BIPHENYL]-4-ACETIC ACID, 4'-[4-[[[(1R)-1-(2-CHLOROPHENYL)ETHOXY]CARBONYL]AMINO]-3-METHYL-5-ISOXAZOLYL]-